Fine-tuning adoptive cell therapy for advanced cancers
Adoptive cell transfer immunotherapy is one of the most promising new treatments for people with hard-to-treat cancers. However, the process is complex and needs fine-tuning in order to develop more treatment strategies that will work for more people. In a new study looking at adoptive cell transfer products bearing a transgenic T-cell receptor (TCR), researchers…